CellCarta

CellCarta is a contract research organization (CRO) that provides specialized laboratory testing and integrated sample management services to the biopharmaceutical industry. The company partners with drug developers to address complex biomarker and bioanalytical challenges across the entire development cycle, from discovery through late-stage clinical trials.

The company's technical capabilities span immunology, histopathology, proteomics, and genomics. Its service offerings include custom assay development for clinical trials, end-to-end sample management, and specialized tests such as PD-L1 testing, of which it has performed over 80,000 to date.

CellCarta operates laboratories across five countries: Canada, the United States, Belgium, Australia, and China. The company states a focus on delivering actionable insights through an integrated operational approach.